Clinical trials: Pharmaceutical Care
Chronic Disease
Determinants of Medication Non-Adherence Among Patients With Chronic Diseases in Egyptian Community Pharmacies
Medication non-adherence among patients with chronic diseases is a major public health concern and is associated with poor disease control, increased complications, and higher healthcare costs.
- Trial name
- ADHER-EG (NCT07375550)
- Where
- Egypt
- Volunteers
- 261 people
- Sponsor
- Egyptian Chinese University
Pulmonary TB
Promoting Overall Care and Management Related to Tuberculosis Infection Through Pharmaceutical Care and Text Messaging
This project aims to standardize the management of "Pharmaceutical care with the two-way text messages and incentive for mobile usage during the treatment for tuberculosis patients, to improve the outcomes and compliance, reduce…
- Trial name
- NCT04264221
- Testing
- New management mode
- Where
- 2 sites in Pakistan
- Volunteers
- 600 people
- Sponsor
- Farman Ullah Khan
Diabetes Mellitus, Type 2
Short Message Service for Type 2 Diabetes
Diabetes is a chronic disease where type 1 diabetes (T1D) is due to autoimmune ẞ-cell destruction, usually leading to absolute insulin deficiency, type 2 diabetes (T2D) is due to a progressive loss of ẞ-cell insulin secretion…
- Trial name
- SMS4T2D (NCT04236206)
- Testing
- Mobile Phone Short Message Service
- Where
- Egypt
- Volunteers
- 100 people
- Sponsor
- Alexandria University
Asthma, COPD
Assessment of Adherence to Controller Inhalation Medication in Asthma- and COPD Patients.
The main aim of the study is to evaluate the adherence to controller inhalation medication in asthma and Chronic Obstructive Pulmonary Disease (COPD) in Universitair Ziekenhuis Brussel.
- Conditions
- Asthma, COPD, Adherence, Medication
- Trial name
- NCT03791658
- Testing
- The 12-question TAI, Information from patients file, The Asthma Control Test (ACT)
- Where
- Belgium
- Volunteers
- 141 people
- Sponsor
- Universitair Ziekenhuis Brussel
Depression, Anxiety Disorders
Cognitive and Drug Therapy for Drug-Resistant Depression
To develop an effective combined cognitive therapy (CT) plus drug treatment for patients with drug-resistant depression (DRD) (i.e., depression that is refractory to medication).
- Conditions
- Depression, Anxiety Disorders, Personality Disorders, Drug-resistant Depression
- Trial name
- NCT00000376
- Testing
- Cognitive therapy, Desipramine
- Sponsor
- University of Pennsylvania
Adverse Drug Effect of Opioids, Adverse Drug Effect of Benzodiazepines
Reducing Concurrent Opioid-Benzodiazepine Prescriptions
The purpose of this effort is to use informative e-mails to improve the process of prescribing of opioids and benzodiazepines within the National Capital Region/Military Health System (NCR/MHS), with the aim of decreasing…
- Trial name
- NCT03887247
- Testing
- E-mail Alert
- Where
- United States
- Volunteers
- 2,234 people, healthy volunteers welcome
- Sponsor
- Walter Reed National Military Medical Center
Depressive Disorder
The ACHIEVA Study of Enhanced Pharmacist Care on Antidepressant Use and Response
This a comparative study of enhanced pharmacist care and regular care of patients starting on antidepressants. When providing participants with enhanced care pharmacists will use the Health Professional's Antidepressant…
- Trial name
- NCT00356655
- Testing
- Psychoeducation
- Where
- Canada
- Volunteers
- 106 people
- Sponsor
- University of Alberta
Reproductive Medicine
Evaluate the Interest of the Pre-conceptional Endometrial Immune Profiling to Increase Birth Rates
A prospective, randomized, controlled, open two-arm study to evaluate the interest of the pre-conceptional endometrial immune profiling to increase birth rates.
- Trial name
- PRECONCEPTIO (NCT02262117)
- Testing
- standard care, specific treatment
- Where
- France
- Volunteers
- 493 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Patient Education as Topic, Surveys and Questionnaires
Development and Validation of a Self-administered QUestionnaire to Identify Levers of Adhesion Behavior to Patient's Medication in Order to Adapt the Educational Monitoring.
Medication non-adherence is an economic problem and a major public health challenge. Factors influencing medication adherence can be modelled according to five dimensions: disease, medication, patient and its close relatives…
- Conditions
- Patient Education as Topic, Surveys and Questionnaires, Medication Adherence, Pulmonary Disease, Chronic Obstructive
- Trial name
- QUILAM (NCT02865525)
- Where
- France
- Volunteers
- 282 people
- Sponsor
- University Hospital, Grenoble
Pulmonary Disease, Chronic Obstructive, Heart Failure
Improving Medication Adherence Through a Transitional Care Pharmacy Practice Model
The purpose of this pilot study is to determine if medication adherence is improved by a transitional care pharmacy practice model designed to integrate hospital and community pharmacists in the care and education of patients…
- Trial name
- NCT02047448
- Testing
- Pharmacist Counseling
- Where
- United States
- Volunteers
- 180 people
- Sponsor
- Wilkes University
Obesity, Morbid, Bariatric Surgery Candidate
Use of Mysimba in Patients With Weight Regain After Bariatric Surgery
Although bariatric surgery is currently the most effective treatment for morbid obesity, weight regain occurs in 16-37% of the patients (1). Weight regain is not regularly treated with antiobesity medications (AOMs).
- Conditions
- Obesity, Morbid, Bariatric Surgery Candidate, Medication Persistence
- Trial name
- NCT04902625
- Testing
- Naltrexone-Bupropion Combination
- Where
- Netherlands
- Volunteers
- 116 people
- Sponsor
- Zuyderland Medisch Centrum
Delivery; Trauma, Pelvic Floor; Perineal Rupture, Obstetric
Perineal Preparation for Pregnant Ladies.
Pregnant participants will be recruited at the obstetrics outpatient clinic during their visits 4 weeks before the due date. They are randomized into two groups. The first group will be educated to do digital perineal massage.
- Conditions
- Delivery; Trauma, Pelvic Floor; Perineal Rupture, Obstetric, Pelvic Floor Muscle Weakness
- Trial name
- NCT03287258
- Testing
- 3 program, one program
- Where
- Egypt
- Volunteers
- 400 people, healthy volunteers welcome
- Sponsor
- Kasr El Aini Hospital
Acute Myocardial Infarction
Randomized, Single Center Study About the Impact of an E-learning Dedicated to Myocardial Infarction Patient
Acute coronary syndrome (ACS) is still one of the major cause of morbi-mortality in Europe. After an ACS, patients should be treated with secondary prevention medication to reduce the risk of recurrence.
- Trial name
- NCT03949608
- Testing
- E-learning
- Where
- Switzerland
- Volunteers
- 67 people
- Sponsor
- University of Lausanne Hospitals
Cystic Fibrosis, Cystic Fibrosis Liver Disease
Real World Clinical Outcomes With Novel Modulator Therapy Combinations in People With CF (RECOVER)
RECOVER is a prospective, multicenter observational study designed to measure the real world clinical effectiveness of elexacaftor/tezacaftor/ivacaftor (ETI) triple combination therapy in people with cystic fibrosis initially…
- Conditions
- Cystic Fibrosis, Cystic Fibrosis Liver Disease, Cystic Fibrosis in Children, Adherence, Medication
- Trial name
- RECOVER (NCT04602468)
- Testing
- Elexacaftor/Tezacaftor/Ivacaftor
- Where
- 7 sites in Ireland, United Kingdom
- Volunteers
- 206 people
- Sponsor
- Royal College of Surgeons, Ireland
Adherence, Patient, Atrial Fibrillation
ASsessment of Adherence TO Medication in AtRIAl Fibrillation - an eMonitoring Drug Dispensing Device Study
The ASTORIA study is a prospective cohort single-armed multicenter observational study that aims to assess adherence to rivaroxaban using a high technological electronical pillbox connected to a phone application in a group of…
- Trial name
- ASTORIA (NCT04815161)
- Testing
- Adherence
- Volunteers
- 200 people
- Sponsor
- Oslo University Hospital
Breast Cancer
Mind-Body Medicine Day Care Clinic in Breast Cancer Patients Undergoing Endocrine Therapy
This randomized controlled trial aims to investigate the effectiveness of a mind body day care clinic program of breast cancer patients undergoing endocrine therapy.
- Trial name
- ENDOTK (NCT02669576)
- Testing
- Mind body medicine day care clinic, Usual care
- Where
- Germany
- Volunteers
- 68 people
- Sponsor
- Universität Duisburg-Essen
Opioid-Related Disorders
Trial of Adherence App for Buprenorphine Treatment (TAAB) Study
The purpose of this study is to pilot test a smartphone application that allows video-based directly observed therapy for participants receiving buprenorphine treatment for opioid use disorder in office-based settings.
- Trial name
- NCT03779997
- Testing
- Video-based DOT Application
- Where
- 2 sites in United States
- Volunteers
- 78 people
- Sponsor
- University of Washington
HIV/AIDS, Cognitive Impairment
A Randomized Pilot Trial Evaluating the Impact of a Yoga Intervention on Cognition in Older Adults Infected With HIV
Approximately 50% of people living with HIV (and as many as 80% over the age of 50) have difficulties with cognitive functions such as memory and thinking that can have a profound negative impact on activities of daily living and…
- Conditions
- HIV/AIDS, Cognitive Impairment, Aging, Mobility Limitation
- Trial name
- NCT03071562
- Testing
- Yoga-mindfulness
- Where
- Canada
- Volunteers
- 22 people
- Sponsor
- Adria Quigley
Human Papilloma Virus
Engaging Clinical Champions to Improve HPV Vaccination
This trial will compare two ways to improve communication about HPV vaccination in primary care. The research team will work with primary care clinics. Some clinics will receive communication training from an outside expert.
- Trial name
- NCT05736718
- Testing
- Champion Announcement Approach Training, Traditional Announcement Approach Training
- Where
- 2 sites in United States
- Volunteers
- 47 people, healthy volunteers welcome
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
Hepatitis C, Diagnostic Self Evaluation
HCV Self-testing in Georgia
Self-testing with easy-to-use rapid diagnostic tests has been successfully used for diseases such as HIV. The availability of self-testing has been shown to increase testing rates and testing acceptability in diverse populations…
- Trial name
- NCT04961723
- Testing
- (OraQuick® HCV Self-Test
- Where
- 6 sites in Georgia
- Volunteers
- 1,250 people, healthy volunteers welcome
- Sponsor
- Foundation for Innovative New Diagnostics, Switzerland
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.